Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

5.05
+0.10002.02%
Post-market: 5.130.0800+1.58%19:59 EDT
Volume:2.68M
Turnover:13.72M
Market Cap:610.92M
PE:-7.32
High:5.27
Open:5.04
Low:5.02
Close:4.95
52wk High:5.80
52wk Low:2.12
Shares:120.97M
Float Shares:115.00M
Volume Ratio:1.00
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6897
EPS(LYR):-0.5089
ROE:148.50%
ROA:-31.12%
PB:-8.42
PE(LYR):-9.92

Loading ...

Feb 06, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 10, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Dec 16, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Dec 02, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 26, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 25, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 13, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 16, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Sep 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 16, 2019

Correspondence

[Cover]Correspondence
Sep 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 06, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]